Related Experiment Videos

[Rectal premedication with midazolam in children. A comparative clinical study]

R Piotrowski1, N Petrow

  • 1Institut für Anaesthesiologie und Reanimation, Kantonales Spital Uznach.

Der Anaesthesist
|January 1, 1989
PubMed

Insights

Rectal midazolam is an effective and well-accepted anesthetic premedication for children, with higher doses showing greater sedative effects and good mask acceptance. This method offers a safe alternative to injections and oral routes.

Area of Science:

  • Pediatric Anesthesiology
  • Pharmacology
  • Clinical Medicine

Background:

  • Pediatric anesthetic premedication via injection is often poorly tolerated by children.
  • Oral premedication poses aspiration risks and requires precise timing before anesthesia.
  • Rectal administration offers a less disturbing alternative for children needing sedation.

Purpose of the Study:

  • To evaluate the efficacy, acceptance, and safety of rectal midazolam as premedication in children.
  • To compare two different doses of rectal midazolam (0.4 mg/kg vs. 0.5 mg/kg) with atropine.
  • To assess the sedative-hypnotic effects and acceptance of anesthetic mask induction.

Main Methods:

  • A double-blind study involving 80 healthy children aged 2-10 years undergoing elective surgery.
  • Children were randomly assigned to receive either 0.4 mg/kg or 0.5 mg/kg midazolam rectally, with atropine.
  • Parameters included acceptance of rectal instillation, sedative effects, vital signs, and mask acceptance.

Main Results:

  • Rectal midazolam was well-accepted by 82.5% of children; no respiratory depression or allergic reactions were observed.
  • The higher dose (0.5 mg/kg) resulted in significantly greater sedative effects (tired/drowsy or asleep) compared to the lower dose.
  • Anesthetic mask acceptance was high (92-97%) and comparable between groups.

Conclusions:

  • Rectal midazolam is a safe and effective premedication for pediatric anesthesia, with good patient acceptance.
  • A higher dose of 0.5 mg/kg midazolam provides superior sedative-hypnotic effects compared to 0.4 mg/kg.
  • This route offers a viable alternative to traditional premedication methods, enhancing patient comfort and cooperation.

Related Concept Videos